Filter by: patients
Home > Community Treatment Reports and Side Effects > Rivastigmine Treatment Report
What is Rivastigmine?

Rivastigmine is a cholinergic agent used for the treatment of mild to moderate dementia of the Alzheimer’s type. Rivastigmine has been available in capsule and liquid formulations since 1997. In 2006, it became the first product approved for Parkinson's disease dementia.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Memory problems 10 2 Efficacy_major Efficacy_moderate
Brain fog 6 2 Efficacy_major
Parkinson's Disease 4 0
Other 4 1 Efficacy_none
Loss of short term memory 2 1 Efficacy_slight
Stiffness/Spasticity 1 0

See all 24 patients currently taking Rivastigmine

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 1
Moderate
 0
Mild
 3
None
 4

Commonly reported side effects, conditions, and hospitalizations associated with Rivastigmine

Constipation 1
Paranoia 1
Headaches 1
Falls 1
Panic attacks 1
Sweating excessive 1
See all 9 reported side effects ▼ See top 6 reported side effects ▲

Reported Dosages

Frequently reported dosages based on patients currently taking Rivastigmine. See all 11 dosages ►

  1 PATCH daily 1.5 mg daily 3 mg daily 4.6 mg/24 hr daily 6 mg daily 9 mg daily 9.5 PATCH daily 9.5 mg/24 hr daily 9.6 mg daily 12 mg daily
  4 Number of Patients: 4 1 Number of Patients: 1 2 Number of Patients: 2 4 Number of Patients: 4 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 4 Number of Patients: 4 1 Number of Patients: 1 3 Number of Patients: 3  

Reported Stop Reasons

Why Patients Stopped Taking Rivastigmine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 5   Did not seem to work: 50%
Side effects too severe 4   Side effects too severe: 40%
Doctor's advice 2   Doctor's advice: 20%
Other 1   Other: 10%
Not indicated 1   Not indicated: 10%

See all 9 patients who’ve stopped taking Rivastigmine

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Rivastigmine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Stopped Taking Rivastigmine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Rivastigmine

Always
 4 50%
Usually
 1 13%
Sometimes
 1 13%
Never
 2 25%

Burden

Difficulty being on treatment

Burden of Rivastigmine

Very
 0 0%
Somewhat
 1 13%
A little
 1 13%
Not at all
 6 75%

Cost

Paid out of pocket

Cost of Rivastigmine

$200+
 0 0%
$100-199
 1 20%
$50-99
 0 0%
$25-49
 2 40%
< $25
 2 40%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 27, 2012.